# Hepatitis B Virus Studies

**Type:** Topics  
**Canonical URL:** https://scholariq.org/topics/hepatitis-b-virus-studies/

## Facts

| Field | Value |
| --- | --- |
| Description | This cluster of papers focuses on the epidemiology, clinical management, antiviral therapy, and global burden of hepatitis B virus (HBV) infection. It covers topics such as chronic hepatitis B, hepatocellular carcinoma, viral hepatitis, antiviral therapy, vaccine prevention, and the immune response to HBV infection. |
| Domain | Health Sciences |
| Field | Medicine |
| OpenAlex ID | t10340 |
| Works | 405 |

## Topic papers all

Showing 15 of 405.

- [EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection](https://scholariq.org/papers/easl-2017-clinical-practice-guidelines-on-the-management-of-hepatitis-b-virus/)
- [Asian-Pacific clinical practice guidelines on the management of hepatitis B: a 2015 update](https://scholariq.org/papers/asian-pacific-clinical-practice-guidelines-on-the-management-of-hepatitis-b-a/)
- [Lamivudine for Patients with Chronic Hepatitis B and Advanced Liver Disease](https://scholariq.org/papers/lamivudine-for-patients-with-chronic-hepatitis-b-and-advanced-liver-disease/)
- [Asia–Pacific clinical practice guidelines on the management of hepatocellular carcinoma: a 2017 update](https://scholariq.org/papers/asia-pacific-clinical-practice-guidelines-on-the-management-of-hepatocellular/)
- [Global prevalence and genotype distribution of hepatitis C virus infection in 2015: a modelling study](https://scholariq.org/papers/global-prevalence-and-genotype-distribution-of-hepatitis-c-virus-infection-in/)
- [AASLD guidelines for treatment of chronic hepatitis B](https://scholariq.org/papers/aasld-guidelines-for-treatment-of-chronic-hepatitis-b/)
- [Viral hepatitis B](https://scholariq.org/papers/viral-hepatitis-b/)
- [Association Between Sustained Virological Response and All-Cause Mortality Among Patients With Chronic Hepatitis C and Advanced Hepatic Fibrosis](https://scholariq.org/papers/association-between-sustained-virological-response-and-all-cause-mortality-among/)
- [The global burden of viral hepatitis from 1990 to 2013: findings from the Global Burden of Disease Study 2013](https://scholariq.org/papers/the-global-burden-of-viral-hepatitis-from-1990-to-2013-findings-from-the-global/)
- [Global patterns of hepatocellular carcinoma management from diagnosis to death: the <scp>BRIDGE</scp> Study](https://scholariq.org/papers/global-patterns-of-hepatocellular-carcinoma-management-from-diagnosis-to-death/)
- [NASH limits anti-tumour surveillance in immunotherapy-treated HCC](https://scholariq.org/papers/nash-limits-anti-tumour-surveillance-in-immunotherapy-treated-hcc/)
- [Hepatitis B e Antigen and the Risk of Hepatocellular Carcinoma](https://scholariq.org/papers/hepatitis-b-e-antigen-and-the-risk-of-hepatocellular-carcinoma/)
- [Liver fibrosis progression in human immunodeficiency virus and hepatitis C virus coinfected patients](https://scholariq.org/papers/liver-fibrosis-progression-in-human-immunodeficiency-virus-and-hepatitis-c-virus/)
- [Viral dynamics in hepatitis B virus infection.](https://scholariq.org/papers/viral-dynamics-in-hepatitis-b-virus-infection/)
- [Asian Pacific Association for the Study of the Liver consensus recommendations on hepatocellular carcinoma](https://scholariq.org/papers/asian-pacific-association-for-the-study-of-the-liver-consensus-recommendations/)

## Topic primary papers

Showing 15 of 167.

- [EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection](https://scholariq.org/papers/easl-2017-clinical-practice-guidelines-on-the-management-of-hepatitis-b-virus/)
- [Asian-Pacific clinical practice guidelines on the management of hepatitis B: a 2015 update](https://scholariq.org/papers/asian-pacific-clinical-practice-guidelines-on-the-management-of-hepatitis-b-a/)
- [Lamivudine for Patients with Chronic Hepatitis B and Advanced Liver Disease](https://scholariq.org/papers/lamivudine-for-patients-with-chronic-hepatitis-b-and-advanced-liver-disease/)
- [AASLD guidelines for treatment of chronic hepatitis B](https://scholariq.org/papers/aasld-guidelines-for-treatment-of-chronic-hepatitis-b/)
- [Viral hepatitis B](https://scholariq.org/papers/viral-hepatitis-b/)
- [Hepatitis B e Antigen and the Risk of Hepatocellular Carcinoma](https://scholariq.org/papers/hepatitis-b-e-antigen-and-the-risk-of-hepatocellular-carcinoma/)
- [Viral dynamics in hepatitis B virus infection.](https://scholariq.org/papers/viral-dynamics-in-hepatitis-b-virus-infection/)
- [Hepatitis B genotypes correlate with clinical outcomes in patients with chronic hepatitis B](https://scholariq.org/papers/hepatitis-b-genotypes-correlate-with-clinical-outcomes-in-patients-with-chronic/)
- [Global, regional, and national burden of hepatitis B, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019](https://scholariq.org/papers/global-regional-and-national-burden-of-hepatitis-b-1990-2019-a-systematic/)
- [Risk estimation for hepatocellular carcinoma in chronic hepatitis B (REACH-B): development and validation of a predictive score](https://scholariq.org/papers/risk-estimation-for-hepatocellular-carcinoma-in-chronic-hepatitis-b-reach-b/)
- [Independent risk factors and predictive score for the development of hepatocellular carcinoma in chronic hepatitis B](https://scholariq.org/papers/independent-risk-factors-and-predictive-score-for-the-development-of/)
- [High Levels of Hepatitis B Surface Antigen Increase Risk of Hepatocellular Carcinoma in Patients With Low HBV Load](https://scholariq.org/papers/high-levels-of-hepatitis-b-surface-antigen-increase-risk-of-hepatocellular/)
- [Natural variants of cytotoxic epitopes are T-cell receptor antagonists for antiviral cytotoxic T cells](https://scholariq.org/papers/natural-variants-of-cytotoxic-epitopes-are-t-cell-receptor-antagonists-for/)
- [Patterns of hepatitis B prevalence and seroconversion in hemodialysis units from three continents: The DOPPS](https://scholariq.org/papers/patterns-of-hepatitis-b-prevalence-and-seroconversion-in-hemodialysis-units-from/)
- [Antiviral Intrahepatic T-Cell Responses Can Be Restored by Blocking Programmed Death-1 Pathway in Chronic Hepatitis B](https://scholariq.org/papers/antiviral-intrahepatic-t-cell-responses-can-be-restored-by-blocking-programmed/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.